FibreTuff Medical Biopolymers signs exclusive agreement to supply compounds for 3D printing in the medical market

March 22, 2018

FibreTuff-Medical-Biopolymers-300

BioOhio member FibreTuff Medical Biopolymers, a biomaterials compounder, has entered into an exclusive agreement with Keene Village Plastics to supply FibreTuff PAPC (Polyamide, Polyolefin and Cellulose ) licensed compounds for 3D Printing in the medical market. In the agreement, Keene Village Plastics responsibilities will include manufacturing and distributing FibreTuff PAPC in 1.75mm and 3.0mm size filaments and distribute various PAPC bar and sheet stock.

The two companies, Keene Village Plastics and FibreTuff Medical Biopolymers, have collaborated for several years to develop innovative PAPC filaments. Now entering into an exclusive 1 year agreement, FibreTuff and KVP are excited to advance the PAPC filament to the medical market for 3D printing.

“The FibreTuff PAPC has been formulated to pass the chemical tests performed by NAMSA, a fellow BioOhio member, for Class I medical applications” says Robert Joyce, President of FibreTuff. The company’s material will soon be tested for USP Class VI approval, and according to Joyce, expected to create new applications and markets in the medical industry. Furthermore, Joyce says the company is targeting functional parts that require bio compatibility with specific applications that could require electronic printed circuits.

Precision and quality are a goal for both companies in teaming up to produce 3D printed parts for the medical industry. Tom Hughes, CEO of FibreTuff described the PAPC bar stock as a most exciting new product for CNC machining small parts with impressive accuracy. Hughes also promoted the PAPC as a cost reduction versus other highly engineered resins already in the 3D printing market.

FibreTuff Medical Biopolymers and Keene Village Plastics are poised to produce exceptional 3D printed parts for the medical market from specialty PAPC compounds that are biocompatible in a state of the art filament production facility.

Learn more about FibreTuff Medical Biopolymers, founded in 2015 and based in northwest, Ohio, via their website: www.fibretuff.us. FibreTuff was the lead collaborator in a 2017 Advanced Manufacturing Partnership Grant awarded to CIFT in Toledo from the State of Ohio. Read about this, and other FibreTuff news, via the BioOhio news page.